Brazil already has more than 25 million doses of vaccines against Covid-19 administered. The country has surpassed the mark in the last 24 hours and has so far given 25,293,644 injections against the disease. The number is equivalent to 19,762,485 people who received the first dose throughout the national territory and the remaining 5,531,159, to the administration of the second dose.
This means that 9.4% of Brazilians have already received at least one dose of the vaccine against Covid-19. When considering those fully immunized, the rate drops to 2.6%.
São Paulo continues to lead the ranking of the states with the highest number of injections administered: 6,646,984. Next is Minas Gerais (2,297,840) and Bahia (2,060,848). At the bottom of the list are Roraima (62,424 doses applied), Acre (71,609) and Amapá (72,817).
In proportional numbers, SP falls to the fifth position, with 10.7% of the population immunized. The leadership of this classification is from Mato Grosso do Sul (12.5%), followed by Bahia (11.6%) and Rio Grande do Sul (11.1%). In last place are Rondônia (6.2%), Maranhão (6.1%) and Mato Grosso (5.7%).
In the same period, 78 days after the start of the immunization campaign, the United States had 78.6 million doses administered, according to data from the Our World in Data platform, linked to Oxford University. A number three times higher than the Brazilian. The big obstacle for vaccination against Covid-19 to take off in Brazil once and for all is the shortage of vaccines.
Continues after advertising
The federal government closed agreements for the purchase of vaccines with seven different suppliers: Instituto Butantan, Fiocruz, Covax Facility, Pfizer, Janssen, Precis Medicamentos and União Química. But only two immunizers are currently in use in the country: CoronaVac, produced by the Butantan Institute, and Covishield, the official name for the Oxford-AstraZeneca vaccine, which is produced here by Fiocruz.
The agreements with Pfizer and Janssen were only recently made official and most of the deliveries were for the second half. Covaxin, a vaccine developed by the Indian Bharat Biotech, distributed in Brazil by Precis Medicamentos, and the Russian vaccine Sputnik V, under the responsibility of União Química, are not yet authorized in Brazil. To make matters worse, there was a delay in delivering the doses of Fiocruz.
The delivery scenario should be less hazy only in the second semester when Fiocruz will start producing 100% doses in the national soil of the Oxford vaccine and when there will be the sending of 38 million doses of the Janssen immunizer – which allows immunization in a single stage and the delivery of most Pfizer vaccines (86 million doses).
Check below the vaccination numbers in Brazil:
Continues after advertising
Get the latest news delivered to your inbox
Follow us on social media networks